SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016149
Filing Date
2022-11-03
Accepted
2022-11-03 08:00:53
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ewtx-20220930x10q.htm   iXBRL 10-Q 2151825
2 EX-31.1 ewtx-20220930xex31d1.htm EX-31.1 16969
3 EX-31.2 ewtx-20220930xex31d2.htm EX-31.2 17243
4 EX-32.1 ewtx-20220930xex32d1.htm EX-32.1 7540
5 EX-32.2 ewtx-20220930xex32d2.htm EX-32.2 7617
  Complete submission text file 0001558370-22-016149.txt   6624951

Data Files

Seq Description Document Type Size
6 EX-101.SCH ewtx-20220930.xsd EX-101.SCH 35681
7 EX-101.CAL ewtx-20220930_cal.xml EX-101.CAL 41602
8 EX-101.DEF ewtx-20220930_def.xml EX-101.DEF 158776
9 EX-101.LAB ewtx-20220930_lab.xml EX-101.LAB 364555
10 EX-101.PRE ewtx-20220930_pre.xml EX-101.PRE 277913
52 EXTRACTED XBRL INSTANCE DOCUMENT ewtx-20220930x10q_htm.xml XML 964785
Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40236 | Film No.: 221356322
SIC: 2834 Pharmaceutical Preparations